Protein C Inhibitor—A Novel Antimicrobial Agent

• Erik Malmström,

  Affiliation Department of Clinical Sciences, Section for Clinical and Experimental Infection Medicine, Lund University, Lund, Sweden

  ⨯
• Matthias Mörgelin,

  Affiliation Department of Clinical Sciences, Section for Clinical and Experimental Infection Medicine, Lund University, Lund, Sweden

  ⨯
• Martin Malmsten,

  Affiliation Department of Pharmacy, Uppsala University, Uppsala, Sweden

  ⨯
• Linda Johansson,

  Affiliation Karolinska Institutet, Center for Infectious Medicine, Huddinge University Hospital, Stockholm, Sweden

  ⨯
• Anna Norrby-Teglund,

  Affiliation Karolinska Institutet, Center for Infectious Medicine, Huddinge University Hospital, Stockholm, Sweden

  ⨯
• Oonagh Shannon,

  Affiliation Department of Clinical Sciences, Section for Clinical and Experimental Infection Medicine, Lund University, Lund, Sweden

  ⨯
• Artur Schmidtchen,

  Affiliation Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Lund, Sweden

  ⨯
• Joost C. M. Meijers,

  Affiliation Departments of Vascular and Experimental Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  ⨯
• Heiko Herwald

  * E-mail: Heiko.Herwald@med.lu.se

  Affiliation Department of Clinical Sciences, Section for Clinical and Experimental Infection Medicine, Lund University, Lund, Sweden

  ⨯